Caforio Giovanni

Board Chair and CEO at BMY

Sold, on record
$46.8M
Dollars the filings state
Form 4 sales
19
Latest Feb 6, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • BMYBRISTOL MYERS SQUIBB COBoard Chair and CEO

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BMYPlan not stated
    Aug 2, 2021 2021

    Sold 20,000 shares at $68.58 ($1.4M)

    Caforio Giovanni, Chairman and CEO

    Sold 3.8% of holdings ($36.3M position)508,980 shares leftFiling

  2. 2 Form 4 sale BMYPlan not stated
    Sep 20, 2021 +49 days

    Sold 25,000 shares at $60.64 ($1.5M)

    Caforio Giovanni, Board Chair and CEO

    Sold 4.9% of holdings ($30.9M position)483,980 shares left1x usual sizeFiling

  3. 3 Form 4 sale BMYPlan not stated
    Feb 24, 2022 +157 days

    Sold 30,000 shares at $67.00 ($2M)

    Caforio Giovanni, Board Chair and CEO

    Sold 6.2% of holdings ($32.4M position)453,455 shares left1.2x usual sizeFiling

  4. 4 Form 4 sale BMYPlan not stated
    Mar 21, 2022 +25 days

    Sold 25,000 shares at $71.52 ($1.8M)

    Caforio Giovanni, Board Chair and CEO

    Sold 4.1% of holdings ($43.4M position)581,524 shares left1x usual sizeFiling

  5. 5 Form 4 sale BMYPlan not stated
    Jun 13, 2022 +84 days

    Sold 30,000 shares at $74.04 ($2.2M)

    Caforio Giovanni, Board Chair and CEO

    Sold 5.2% of holdings ($43M position)551,104 shares left1.2x usual sizeFiling

  6. 6 Form 4 sale BMYPlan not stated
    Sep 15, 2022 +94 days

    Sold 50,000 shares at $71.84 ($3.6M)

    Caforio Giovanni, Board Chair and CEO

    Sold 9.1% of holdings ($39.6M position)501,104 shares left2x usual sizeFiling

  7. 7 Form 4 sale BMYPlan not stated
    Sep 20, 2022 +5 days

    Sold 25,000 shares at $69.71 ($1.7M)

    Caforio Giovanni, Board Chair and CEO

    Sold 5% of holdings ($34.9M position)476,104 shares left1x usual sizeFiling

  8. 8 Form 4 sale BMYUnusual
    Feb 6, 2023 +139 days

    Sold 240,000 shares at $74.65 ($17.9M)

    Caforio Giovanni, Board Chair and CEO

    Sold 50.4% of holdings ($35.5M position)236,104 shares left9.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (19)

Form 144 notices and Form 4 sales by Caforio Giovanni
Source
Feb 6, 2023Feb 8, 2023BMYBoard Chair and CEOForm 4 sale240,000$17.9M50.4%UnusualSEC
Sep 20, 2022Sep 22, 2022BMYBoard Chair and CEOForm 4 sale25,000$1.7M5.0%Plan not statedSEC
Sep 15, 2022Sep 16, 2022BMYBoard Chair and CEOForm 4 sale50,000$3.6M9.1%Plan not statedSEC
Jun 13, 2022Jun 14, 2022BMYBoard Chair and CEOForm 4 sale30,000$2.2M5.2%Plan not statedSEC
Mar 21, 2022Mar 23, 2022BMYBoard Chair and CEOForm 4 sale25,000$1.8M4.1%Plan not statedSEC
Feb 24, 2022Feb 28, 2022BMYBoard Chair and CEOForm 4 sale30,000$2M6.2%Plan not statedSEC
Sep 20, 2021Sep 22, 2021BMYBoard Chair and CEOForm 4 sale25,000$1.5M4.9%Plan not statedSEC
Aug 2, 2021Aug 4, 2021BMYChairman and CEOForm 4 sale20,000$1.4M3.8%Plan not statedSEC
Mar 22, 2021Mar 24, 2021BMYChairman and CEOForm 4 sale25,000$1.6M4.5%Plan not statedSEC
Aug 31, 2020Sep 2, 2020BMYChairman and CEOForm 4 sale39,840$2.5M8.2%Plan not statedSEC
May 3, 2016May 5, 2016BMYChief Executive OfficerForm 4 sale34,594$2.5M21.5%Plan not statedSEC
Feb 17, 2016Feb 19, 2016BMYChief Executive OfficerForm 4 sale12,040$766k13.6%Plan not statedSEC
Sep 15, 2014Sep 16, 2014BMYChief Operating OfficerForm 4 sale26,691$1.3M39.6%UnusualSEC
Feb 24, 2014Feb 25, 2014BMYEVP & Chief Commercial OfficerForm 4 sale41,563$2.3M45.5%UnusualSEC
May 31, 2013May 31, 2013BMYPres., US PharmaceuticalsForm 4 sale10,538$496k18.2%Plan not statedSEC
May 23, 2013May 23, 2013BMYPres., US PharmaceuticalsForm 4 sale26,647$1.2M31.5%UnusualSEC
Feb 27, 2013Feb 27, 2013BMYPres., US PharmaceuticalsForm 4 sale12,150$451k19.0%Plan not statedSEC
Jan 28, 2013Jan 28, 2013BMYPres., US PharmaceuticalsForm 4 sale20,350$736k24.1%Plan not statedSEC
Aug 24, 2012Aug 28, 2012BMYPres., US PharmaceuticalsForm 4 sale25,900$847k31.1%UnusualSEC